The need for chemical prophylaxis against Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), collectively referred to as Venous Thromboembolism (VTE), following certain orthopaedic surgeries has been well established. For example, the use of chemical prophylaxis agents in total hip and knee surgeries, as well as in hip fracture surgeries, is routine.